![]() |
市場調查報告書
商品編碼
2088058
傳統和補充醫學市場預測至2034年:按療法、分銷管道、應用領域、最終用戶和地區分類的全球分析Traditional and Complementary Medicine Market Forecasts to 2034 - Global Analysis By Therapy Type, Distribution Channel, Application Area, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球傳統和補充醫學市場規模將達到 938 億美元,並在預測期內以 26.4% 的複合年成長率成長,到 2034 年將達到 6,112 億美元。
傳統與補充醫學(T&CM)涵蓋了廣泛的治療體系、實踐和理念,其核心在於整體健康,包括草藥、針灸、阿育吠陀、瑜伽和脊骨神經醫學。它通常與傳統醫學結合使用,旨在預防疾病、控制症狀並改善整體健康。由於人們對自然療法和預防醫學的需求不斷成長,傳統與補充醫學在全球的接受度日益提高。人們選擇這些療法是因為它們副作用較少,並且符合文化傳統。衛生部門和政府正日益將傳統與補充醫學納入公共醫療保健體系。持續的研究、監管和標準化工作正在提升其安全性、可靠性和全球醫療保健整合水準。
根據世界衛生組織(世衛組織)的數據,傳統、補充和整合醫學(TCIM)目前已納入 100 多個國家的醫療保健系統,106 個成員國向 2024 年全球調查提交了數據。
對自然療法和整體醫療保健的需求日益成長
人們對自然療法和整體健康護理的日益偏好,正顯著推動傳統和輔助醫療保健市場的發展。消費者越來越傾向於選擇以預防為主、注重整體平衡而非僅僅治療症狀的保健方式。中醫、瑜伽、針灸和阿育吠陀等療法因其被認為更安全、副作用更少而廣受歡迎。人們對文明病的認知不斷提高,以及對傳統醫療保健局限性的擔憂,進一步推動了這一轉變。文化傳統和自然療法的歷史應用也為其流行提供了支持。此外,健康意識的增強、自我護理習慣的養成以及草藥和天然產品的獲取途徑日益便捷,都在加速全球市場的擴張。
缺乏科學證據和缺乏標準化
科學檢驗不足和缺乏標準化實踐是傳統和補充醫學市場的主要阻礙因素。許多療法,包括草藥、針灸和阿育吠陀療法,尚未經過廣泛的臨床試驗來驗證其基於現代醫學標準的安全性和有效性。處方差異、劑量不一致以及缺乏統一的治療指南,都削弱了患者和醫療專業人員的信心。這導致人們在採用這些療法時猶豫不決,尤其是在醫療體系發達的地區。研究投入不足進一步延緩了對這些療法的適當評估。因此,儘管這些療法越來越受歡迎,但人們對其臨床可靠性和有效性的疑慮仍然阻礙著它們在全球範圍內被主流醫療機構全面接納。
健康與醫療旅遊的擴張
健康與醫療旅遊的蓬勃發展為傳統和輔助醫學市場創造了巨大的成長機會。越來越多的遊客尋求整體療法,包括阿育吠陀療法、瑜珈靜修和傳統水療服務。擁有豐富傳統療癒體系的國家正成為熱門目的地,提供價格合理的健康照護。政府對旅遊業發展的支持進一步加速了這一趨勢。日益成長的壓力、與生活方式相關的慢性疾病以及對放鬆療法的需求不斷增加,也推動了人們對健康旅遊的興趣。將傳統療法融入高階酒店服務,進一步提升了其吸引力。總而言之,健康旅遊的擴張顯著提升了全球醫療保健系統的知名度和收入潛力。
監管機構加強監督並實施更嚴格的監管
監管力度加大和政策限制給傳統和補充醫學市場帶來了巨大挑戰。許多國家政府對草藥和替代療法實施了嚴格的核准要求。這些措施要求提供強而有力的臨床證據、安全評估和標準化的生產規範,而對於研發能力有限的傳統醫療體係而言,往往難以達到這些要求。國際監管的不一致進一步加劇了跨境貿易的複雜性,阻礙了市場准入,減緩了行業成長,同時也加重了全球小規模企業和傳統醫學從業者的營運負擔。因此,該領域的全球擴張和創新受到限制,對當今整體市場發展產生了重大影響。
新冠疫情顯著影響了傳統和輔助醫學市場,全球對增強免疫力療法和預防性醫療保健的需求激增。疫情期間,許多人轉向草藥、阿育吠陀療法和其他傳統療法,以維持免疫健康和應對輕微感染疾病。傳統醫療系統壓力增大,醫療資源有限,促使人們更依賴替代療法。然而,供應鏈中斷和監管延遲對產品分銷造成了暫時性影響。整體而言,疫情顯著提高了世界各地人們對整體和自然療法的認知、接受度和使用率。
在預測期內,傳統草藥市場預計將佔據最大的市場佔有率。
由於其悠久的使用歷史、深厚的文化底蘊和較高的全球滲透率,預計傳統草藥市場在預測期內將佔據最大的市場佔有率。該市場依賴植物來源的成分和天然療法,用於治療和預防各種健康問題。許多消費者更傾向於選擇草藥療法,因為它們比傳統藥物更安全、更經濟實惠且更容易獲得。草藥是阿育吠陀、傳統中醫以及各種本土傳統療法等成熟醫療體系的重要組成部分。人們對天然、有機和植物來源醫療保健解決方案日益成長的偏好,並持續鞏固草藥的主導地位,使其成為全球使用最廣泛的治療類別。
在預測期內,心理健康和壓力管理領域預計將呈現最高的複合年成長率。
在預測期內,受全球壓力、焦慮和其他精神障礙病例增加的推動,心理健康和壓力管理領域預計將呈現最高的成長率。快節奏的生活方式、職場壓力、城市生活以及持續接觸數位環境等因素正在對心理健康產生負面影響,並促使人們對整體和自然療法的需求不斷成長。瑜珈、冥想、正念、針灸和草藥等療法正擴大被用於恢復情緒穩定和降低壓力水平。此外,人們對心理健康問題的認知不斷提高、社會歧視減少以及這些療法被納入健康計劃,共同推動了全球市場的強勁成長。
在預測期內,亞太地區預計將佔據最大的市場佔有率,這主要得益於其深厚的文化底蘊,包括阿育吠陀、傳統中醫以及各種本土療法等治療體系。該地區人口基數大規模,健康意識不斷提高,且對自然療法的接受度很高,這些因素都為其發展提供了強大支撐。在中國、印度和日本等國家,系統化的傳統醫療體系在政府的積極支持和與主流醫療保健體系的整合下得以延續。對草藥產品、天然保健方案和經濟實惠的治療方案日益成長的需求,持續推動該地區在全球傳統和輔助醫學市場的主導地位。此外,不斷擴大的研究活動和活性化的醫療旅遊業也進一步鞏固了該地區在全球傳統和輔助醫學市場的主導地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於人們對整體醫療保健日益成長的偏好以及政府強力的政策支持。不斷提高的健康意識、不斷壯大的都市區以及日益加重的慢性病負擔,都在推動對預防性和自然療法的需求。印度和中國等主要經濟體正在加大對傳統療法與現代醫療保健體系融合的研究、監管和整合投入。健康旅遊的興起、數位醫療的普及以及草藥產品的國際貿易進一步促進了市場成長。較高的文化接受度確保了亞太地區市場在全球範圍內的持續快速擴張。
According to Stratistics MRC, the Global Traditional and Complementary Medicine Market is accounted for $93.8 billion in 2026 and is expected to reach $611.2 billion by 2034 growing at a CAGR of 26.4% during the forecast period. Traditional and Complementary Medicine (T&CM) encompasses a wide range of healing systems, practices, and beliefs such as herbal medicine, acupuncture, Ayurveda, yoga, and chiropractic therapies, focusing on holistic health. It is commonly combined with conventional medical treatments to help prevent illness, manage conditions, and improve overall wellness. Rising demand for natural and preventive care has boosted its acceptance worldwide. People choose these therapies because they offer fewer side effects and align with cultural traditions. Health authorities and governments are increasingly incorporating T&CM into official healthcare frameworks. Ongoing studies, regulation, and standardization efforts are improving safety, reliability, and global healthcare integration.
According to the World Health Organization (WHO), traditional, complementary, and integrative medicine (TCIM) is now integrated into health systems across more than 100 countries, with 106 Member States contributing data to the 2024 global survey.
Increasing demand for natural and holistic healthcare
Growing preference for natural and holistic healthcare significantly drives the Traditional and Complementary Medicine market. Consumers increasingly choose preventive and wellness-focused approaches that prioritize overall balance instead of only treating symptoms. Practices such as herbal medicine, yoga, acupuncture, and Ayurveda are widely adopted because they are considered safer and associated with fewer side effects. Awareness of chronic lifestyle diseases and limitations of conventional medicine is further encouraging this shift. Cultural traditions and historical use of natural therapies also support adoption. In addition, rising wellness awareness, self-care habits, and easier access to herbal and natural products are accelerating global market expansion.
Lack of scientific evidence and standardization
Insufficient scientific validation and absence of standardized practices are key restraints in the Traditional and Complementary Medicine market. Many therapies, including herbal medicine, acupuncture, and Ayurveda, lack extensive clinical trials confirming their safety and effectiveness under modern medical standards. Variations in formulations, inconsistent dosages, and the lack of uniform treatment guidelines reduce trust among patients and healthcare professionals. This leads to hesitation in adoption, particularly in advanced healthcare systems. Limited investment in research further delays proper evaluation. Consequently, despite rising popularity, doubts regarding clinical reliability and effectiveness continue to hinder full integration into mainstream global healthcare practices.
Expansion of wellness and medical tourism
Growth in wellness and medical tourism offers substantial opportunities for the Traditional and Complementary Medicine market. Increasing numbers of tourists are seeking holistic treatments including Ayurveda therapies, yoga retreats, and traditional spa services. Countries with rich traditional healing systems are becoming popular destinations for affordable wellness care. Government support for tourism development is further accelerating this trend. Rising stress, chronic lifestyle conditions, and demand for relaxation therapies are also boosting interest. The integration of traditional healing practices into luxury hospitality services enhances attractiveness. Overall, expanding wellness tourism significantly increases global exposure and revenue potential for complementary healthcare systems globally.
Increasing regulatory scrutiny and restrictions
Stricter regulatory oversight and policy restrictions represent a significant challenge for the Traditional and Complementary Medicine market as many governments introduce rigorous approval requirements for herbal medicines and alternative treatment methods. These measures demand strong clinical evidence, safety assessments, and standardized production practices, which traditional healthcare systems often find difficult to comply with due to limited research capabilities. Global inconsistencies in regulation further complicate cross-border trade, reducing market accessibility and slowing industry growth while increasing operational burdens on small providers and traditional practitioners worldwide, ultimately restricting expansion and innovation in the sector globally today market development overall significantly affected here.
The COVID-19 outbreak strongly influenced the Traditional and Complementary Medicine market by increasing demand for immunity-enhancing and preventive healthcare options worldwide. Many individuals adopted herbal treatments, Ayurveda, and other traditional healing methods to support immune health and manage mild infections during the crisis. Strains on conventional healthcare systems and restricted access to medical facilities encouraged reliance on alternative therapies. However, disruptions in supply chains and regulatory delays impacted product distribution temporarily. Overall, the pandemic boosted awareness, acceptance, and usage of holistic and natural healthcare approaches across global populations significantly.
The traditional herbal medicine segment is expected to be the largest during the forecast period
The traditional herbal medicine segment is expected to account for the largest market share during the forecast period because of its long-standing historical use, strong cultural relevance, and widespread availability worldwide. It relies on plant-derived ingredients and natural remedies used for managing and preventing various health issues. Many consumers favor herbal treatments due to their perceived safety, affordability, and easier access compared to conventional pharmaceuticals. It is an integral part of established systems like Ayurveda, traditional Chinese medicine, and various indigenous healing traditions. Growing preference for natural, organic, and plant-based healthcare solutions continues to support its leading position, making it the most widely used therapy category globally.
The mental health & stress management segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the mental health & stress management segment is predicted to witness the highest growth rate, driven by increasing cases of stress, anxiety, and other psychological disorders worldwide. Factors such as hectic lifestyles, workplace pressure, urban living, and constant digital exposure are negatively affecting mental well-being, encouraging demand for holistic and natural healing approaches. Therapies like yoga, meditation, mindfulness practices, acupuncture, and herbal solutions are increasingly used to restore emotional stability and reduce stress levels. Growing awareness of mental health issues and reduced social stigma, along with integration into wellness programs, is accelerating strong global market growth.
During the forecast period, the Asia-Pacific region is expected to hold the largest market share because of deep-rooted cultural heritage in healing systems like Ayurveda Traditional Chinese Medicine and various indigenous practices. The region is supported by large population base increasing health awareness and strong acceptance of natural treatment methods. Countries such as China India and Japan maintain structured traditional medicine systems with active government support and integration into mainstream healthcare. Rising demand for herbal products natural wellness solutions and affordable therapies continues to drive market leadership. Furthermore growing research initiatives and medical tourism activities reinforce the region's leading position in the global Traditional and Complementary Medicine market.
Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, supported by rising preference for holistic healthcare and strong policy backing from governments. Increasing health consciousness, a growing urban middle class, and a higher burden of chronic diseases are boosting demand for preventive and natural treatment options. Major economies like India and China are investing in research, regulation, and integration of traditional therapies with modern healthcare systems. Growth is further supported by expanding wellness tourism, digital healthcare adoption, and international trade of herbal products. Strong cultural acceptance ensures sustained and rapid regional market expansion globally.
Key players in the market
Some of the key players in Traditional and Complementary Medicine Market include Patanjali Ayurved, Dabur India, Himalaya Wellness, Baidyanath, Zandu Pharmaceutical Works, Schwabe Group, Herbalife Nutrition, Blackmores Group, Weleda, Boiron Group, Nature's Bounty, Integria Healthcare, Pure Encapsulations, Herb Pharm, Tsumura, Yunnan Baiyao, Tongrentang and TASLY.
In April 2026, Dabur announced a strategic partnership with WNNR as part of its first-party data initiative for its flagship e-commerce platform, daburshop.com. As part of the collaboration, WNNR will enable a privacy-first approach, ensuring that all user data from daburshop.com is collected ethically, with explicit consent, and in compliance with India's data protection framework and global standards.
In March 2025, Patanjali Ayurved acquires stake in Magma General Insurance with SNG & Partners' legal expertise, valuing the company at ₹ 4,500 Crore. DS Group is also purchasing 24.5% equity shares. This acquisition signifies Patanjali's expansion into financial services. The strategic advisory led by Ravi Bhadani was crucial in navigating the complex transaction.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.